PharmaSGP Holding SE
FSX:PSG.DE
21.2 (EUR) • At close September 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 101.099 | 85.824 | 65.344 | 63.246 | 62.574 | 60.595 | 53.062 |
| Cost of Revenue
| 26.1 | 9.032 | 6.488 | 6.206 | 5.868 | 10.302 | 7.908 |
| Gross Profit
| 74.999 | 76.792 | 58.856 | 57.04 | 56.706 | 50.293 | 45.154 |
| Gross Profit Ratio
| 0.742 | 0.895 | 0.901 | 0.902 | 0.906 | 0.83 | 0.851 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 6.998 | 0 | 0.942 | 2.947 | 0.303 | 3.989 | 3.636 |
| Selling & Marketing Expenses
| 43.381 | 37.378 | 30.843 | 31.646 | 27.824 | 26.96 | 26.364 |
| SG&A
| 50.379 | 37.378 | 31.785 | 34.593 | 28.127 | 30.949 | 30 |
| Other Expenses
| 0.172 | 0.386 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 50.207 | 59.109 | 43.364 | 40.966 | 32.223 | 30.949 | 30 |
| Operating Income
| 24.792 | 17.596 | 15.422 | 16.049 | 24.402 | 19.344 | 15.154 |
| Operating Income Ratio
| 0.245 | 0.205 | 0.236 | 0.254 | 0.39 | 0.319 | 0.286 |
| Total Other Income Expenses Net
| -2.899 | -1.793 | -1.216 | -1.9 | -2.139 | 0.194 | 0.155 |
| Income Before Tax
| 21.893 | 15.803 | 14.206 | 14.149 | 22.263 | 19.538 | 15.309 |
| Income Before Tax Ratio
| 0.217 | 0.184 | 0.217 | 0.224 | 0.356 | 0.322 | 0.289 |
| Income Tax Expense
| 5.496 | 3.849 | 3.516 | 3.509 | 5.557 | 4.805 | 3.526 |
| Net Income
| 16.397 | 11.954 | 10.69 | 10.64 | 16.706 | 14.733 | 11.783 |
| Net Income Ratio
| 0.162 | 0.139 | 0.164 | 0.168 | 0.267 | 0.243 | 0.222 |
| EPS
| 1.37 | 1 | 0.89 | 0.89 | 1.39 | 1.23 | 0.98 |
| EPS Diluted
| 1.37 | 1 | 0.89 | 0.89 | 1.39 | 1.23 | 0.98 |
| EBITDA
| 34.088 | 26.846 | 18.995 | 16.535 | 24.799 | 19.731 | 15.565 |
| EBITDA Ratio
| 0.337 | 0.313 | 0.291 | 0.261 | 0.396 | 0.326 | 0.293 |